Joshua M. Lang

Also affiliated with University of Wisconsin Carbone Cancer Center, Wisconsin Division of Public Health

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 43 papers. Top paper: “BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity”.

BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity

Nucleic Acids Research(2021)10.1093/nar/gkab1122

N/A

1.7DataRank · unranked

66 citations

Peng Liu, Shengjie Zhang, Kristine Donahue, Yidan Wang, Jennifer L. Schehr +12 more

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004198

N/A

1.2DataRank · unranked

52 citations

Jens C. Eickhoff, Ellen Wargowski, Laura E. Johnson, Christos E. Kyriakopoulos, Hamid Emamekhoo +4 more

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

Molecular Oncology(2021)10.1002/1878-0261.12931

N/A

0.959DataRank · unranked

22 citations

Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino +16 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0.635DataRank · unranked

68 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0.561DataRank · unranked

41 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

npj Precision Oncology(2024)10.1038/s41698-024-00599-6

N/A

0.529DataRank · unranked

33 citations

Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman, Navonil De Sarkar +24 more

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci161858

N/A

0.529DataRank · unranked

33 citations

Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh +34 more

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

Cancers(2022)10.3390/cancers14030757

N/A

0.520DataRank · unranked

31 citations

Erika Héninger, Cristina Sánchez‐de‐Diego, Adeline B. Ding, Ravi Chandra Yada, Sheena C. Kerr +4 more

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2567

N/A

0.494DataRank · unranked

26 citations

Nicholas R. Rydzewski, Meng Zhang, Arian Lundberg, Matthew L. Bootsma, Kyle T. Helzer +7 more

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4604

N/A

0.464DataRank · unranked

21 citations

Theodore Karrison, Bradley A. McGregor, Pedro C. Barata, Himanshu Nagar, Chad Tang +10 more

Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.040

N/A

0.434DataRank · unranked

17 citations

Brett Morris, Nan Sethakorn, Joshua M. Lang, Jennifer L. Schehr, Shuang G. Zhao +9 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0.425DataRank · unranked

16 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response

Communications Biology(2025)10.1038/s42003-025-08384-2

N/A

0.422DataRank · unranked

13 citations

Ravi Chandra Yada, Nan Sethakorn, Peter Geiger, Adeline B. Ding, Erika Héninger +11 more

Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone

npj Genomic Medicine(2022)10.1038/s41525-022-00328-7

N/A

0.411DataRank · unranked

8 citations

Kyle T. Helzer, Yeonhee Park, Yi Chen, Nicholas R. Rydzewski, Matthew L. Bootsma +8 more

Reversible Epigenetic Alterations Regulate Class I HLA Loss in Prostate Cancer

Research Square(2021)10.21203/rs.3.rs-894353/v1

N/A

0.292DataRank · unranked

6 citations

Erika Henninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology(2025)10.1002/1878-0261.70001

N/A

0.280DataRank · unranked

4 citations

Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi +22 more

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates

Research Square(2023)10.21203/rs.3.rs-3745991/v1

N/A

0.241DataRank · unranked

4 citations

Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman +22 more

A platform-independent AI tumor lineage and site (ATLAS) classifier

Communications Biology(2024)10.1038/s42003-024-05981-5

N/A

0.165DataRank · unranked

2 citations

Yue Shi, Chenxuan Li, Matthew R. Chrostek, Hamza Bakhtiar, Kyle T. Helzer +15 more

TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5060

N/A

0.165DataRank · unranked

2 citations

Jamie M. Sperger, Susan F. Slovin, Scott T. Tagawa, Christos E. Kyriakopoulos, Manish Kohli +5 more

Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.547

N/A

0.104DataRank · unranked

1 citations

Hamid Emamekhoo, Katherine R. Kaufmann, Petros Grivas, Moshe Chaim Ornstein, Iris Yeong- Fung Sheng +9 more

Live Cell Sorting of Differentiated Primary Human Osteoclasts Allows Generation of Transcriptomic Signature Matrix

Research Square(2025)10.21203/rs.3.rs-6157400/v1

N/A

0DataRank · unranked

0 citations

Adeline B. Ding, Erika Héninger, Shannon R. Reese, Kyle T. Helzer, Xavier Hazelberg +7 more

OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.28.656673

N/A

0DataRank · unranked

0 citations

Ángel Alberto Ruíz-Chow, Johnny A. Diaz, Nicholas M. Nunley, Rachel Dove, Shile Zhang +20 more

Quantifying partial pathological response rate in prostate cancer patients who underwent neoadjuvant chemotherapy using a novel morphometric approach

Journal of Pathology Informatics(2025)10.1016/j.jpi.2025.100528

N/A

0DataRank · unranked

0 citations

Huihua Li, Philipos Tsourkas, Sean J. McIlwain, Irene M. Ong, Christos E. Kyriakopoulos +8 more

Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.247

N/A

0DataRank · unranked

1 citations

Jamie M. Sperger, Marina N. Sharifi, Yue Shi, Charlotte N. Stahlfeld, Jennifer L. Schehr +9 more

A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation

Integrative Biology(2020)10.1093/intbio/zyaa020

N/A

0DataRank · unranked

20 citations

Molly Morgan, Amani A. Gillette, Megan K. Livingston, Karina M. Lugo-Cintrón, Peter F. Favreau +6 more

ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer

European Journal of Nuclear Medicine and Molecular Imaging(2021)10.1007/s00259-021-05563-1

N/A

0DataRank · unranked

49 citations

Miao Li, Muhsin H. Younis, Todd E. Barnhart, Dawei Jiang, Tuanwei Sun +5 more

Volumeless reagent delivery: a liquid handling method for adding reagents to microscale droplets without increasing volume

Lab on a Chip(2021)10.1039/d1lc00906k

N/A

0DataRank · unranked

11 citations

Joshua M. Lang, David J. Beebe, Duane S. Juang

A role for microfluidic systems in precision medicine

Nature Communications(2022)10.1038/s41467-022-30384-7

N/A

0DataRank · unranked

205 citations

Marı́a Virumbrales-Muñoz, Joshua M. Lang, David J. Beebe, José M. Ayuso

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Communications Biology(2022)10.1038/s42003-022-03843-6

N/A

0DataRank · unranked

52 citations

Erika Héninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer

Biomarker Research(2022)10.1186/s40364-022-00370-8

N/A

0DataRank · unranked

7 citations

Nan Sethakorn, Zachery D. Schultz, Camila I. Hernandez, Rory M. Bade, Diego Eyzaguirre +10 more

Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment

The Prostate(2022)10.1002/pros.24326

N/A

0DataRank · unranked

5 citations

Wei Huang, Peter Geiger, Erika Héninger, Joshua M. Lang, David F. Jarrard +3 more

Single cell phenotyping of PDL1 and HLA1 on circulating tumor cells (CTC) in clear cell renal cell carcinoma (ccRCC) on systemic treatment with immunotherapy (IO) and vascular endothelial growth factor receptor tyrosine kinase inhibitors (TKI).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.381

N/A

0DataRank · unranked

0 citations

Matthew C. Mannino, Matthew L. Bootsma, Rory M. Bade, Meghan Wells, Jennifer L. Schehr +5 more

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

Annals of Oncology(2023)10.1016/j.annonc.2023.06.001

N/A

0DataRank · unranked

67 citations

Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma +29 more

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1305

N/A

0DataRank · unranked

54 citations

Kyle T. Helzer, Charlotte N. Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R. Kaufmann +19 more

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Oncotarget(2023)10.18632/oncotarget.28477

N/A

0DataRank · unranked

7 citations

Bing Yang, Tanaya A. Purohit, Jennifer L. Schehr, Anupama Singh, Marcelo Bigarella +5 more

Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer

Molecular Oncology(2020)10.1002/1878-0261.12687

N/A

0DataRank · unranked

22 citations

Ryan A. Denu, Serena K. Wolfe, Jamie M. Sperger, Jennifer L. Schehr, Tessa Witkowsky +6 more

BMX inhibition and HSD3B1-driven resistance in prostate cancer in the Maverick trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.144

N/A

0DataRank · unranked

0 citations

Rana R. McKay, Jake Vinson, Mike A. Royal, Joshua M. Lang, Eric A. Klein +12 more

Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0248

N/A

0DataRank · unranked

20 citations

Hallie M. Hintz, Gihan S. Gunaratne, Matthew T. Breneman, Emma E. Recchia, Jayden L. West +12 more

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Nature Communications(2025)10.1038/s41467-025-64153-z

N/A

0DataRank · unranked

8 citations

Marina N. Sharifi, Jamie M. Sperger, Matthew R. Chrostek, Matthew L. Bootsma, Shannon R. Reese +22 more

Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma

Pigment Cell & Melanoma Research(2025)10.1111/pcmr.70030

N/A

0DataRank · unranked

4 citations

Shuang G. Zhao, Benjamin K. Gibbs, Jennifer L. Schehr, Isabella G. Fernandez, Diego Eyzaguirre +8 more

The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library

Communications Biology(2025)10.1038/s42003-025-08610-x

N/A

0DataRank · unranked

2 citations

Joseph P. Gallant, Kendahl L. Ott, Payson Broome, Sasha Celada, Jayden L. West +11 more

Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.232

N/A

0DataRank · unranked

1 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, Kyle T. Helzer +10 more

Investigating clinical associations between genomic alterations and prostate cancer lineage states using circulating tumor cell RNA sequencing.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.256

N/A

0DataRank · unranked

0 citations

Joshua M. Lang, Marina N. Sharifi, Jamie M. Sperger, Shannon R. Reese, Amy K. Taylor +8 more